AI and accelerated computing are transforming the bio/pharmaceutical sector by addressing organizational, technological, and ...

"The threshold debate in Norway" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.

The latest update is out from Fusen Pharmaceutical Co., Ltd. ( ($HK:1652) ). Fusen Pharmaceutical Co., Ltd. announced the approval of its ...

The draft guidance, which is touted as a way to reduce the cost and time-associated burden of biosimilar development, has ...

Laxxon Medical, a leading pharmaceutical technology company, pioneering a new generation of advanced oral drug delivery systems, today announced that it will be attending BIO-Europe 2025 and the ...

Central Committee has announced the list of 10 young scientists who have won the 2025 Golden Globe Science and Technology ...

Regeneron has once again received a complete response letter (CRL) from the US Food and Drug Administration (FDA) for the ...

"Eli Lilly and NVIDIA to build pharma’s “most powerful” supercomputer" was originally created and published by Pharmaceutical ...

Radiopharmaceuticals provide targeted cancer treatment, minimizing side effects and offering a theranostic approach for precise diagnosis and therapy. Challenges include global demand, isotope supply, ...

Eleven Chinese healthcare and biotechnology companies filed applications to list on the Hong Kong stock exchange in the last two days of September, taking advantage of an ongoing investment boom in ...

South Africa's biggest pharmaceutical producer Aspen Pharmacare said on Friday it had reached a 25 million euro ($29.2 ...

In today’s Pharmaceutical Executive Daily, we cover Thermo Fisher’s $8 billion agreement to acquire Clario Holdings, Eli ...